Premium
Newer aspects of migraine preventive therapies
Author(s) -
Freitag Frederick G.
Publication year - 2007
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.20194
Subject(s) - topiramate , migraine , medicine , migraine treatment , timolol , divalproex , flunarizine , amitriptyline , propranolol , pharmacology , intensive care medicine , anesthesia , psychiatry , epilepsy , mood , mania , intraocular pressure , bipolar disorder , calcium
Migraine preventive therapy includes treatment with pharmacological therapies that result in the reduction of the frequency, severity, or intensity of attacks. There are sufficient data to make recommendations for the following seven pharmacological agents for migraine prevention: topiramate, divalproex sodium, amitriptyline, metoprolol, propranolol, timolol, and Petasites. Additional evidence and treatment recommendations are reviewed on the specific efficacy and safety of several other therapies tested for migraine prevention. Drug Dev Res 68:315–320, 2007. © 2007 Wiley‐Liss, Inc.